Topical and systemic antifungals in dermatology practice

References

• Borman AM, Campbell CK, Fraser M, et al. Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades. Med Mycology. 2007;45(2):131–141. ​​ ​​
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, Lea & Febiger, 1992. 866p. ill. ISBN: 0-8121-1463-9. ​​
   Google Scholar
• Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev. 1995;8(2):240–259.
   PubMed Web of Science ®Google Scholar
• Weitzman I, McGinnis M, Padhye A, et al. The genus Arthroderma and its later synonym. Nannizzia. Mycotaxon. 1986;25:505–518.
   Web of Science ®Google Scholar
• Deng S, Zhang C, Seyedmousavi S, et al. Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum. Antimicrob Agents Chemother. 2015;59(7):4312–4314.
   PubMed Web of Science ®Google Scholar
• Deng S, De Hoog GS, Verweij PE, et al. In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients. J Antimicrob Chemother. 2015;70(4):1072–1075.
   PubMed Web of Science ®Google Scholar
• Zhan P, Li DM, Wang C, et al. Epidemiological changes in tinea capitis over the sixty years of economic growth in China. Med Mycology. 2015;53(7):691–698.
   PubMed Web of Science ®Google Scholar
• Pereiro MJ, Pereiro M, Pereiro-Miguens M, et al. Mycoses caused by Trichophyton megninii in Galicia (with review of the taxonomy of this dermatophyte). J Med Vet Mycology. 1988;26(2):93–100.
   PubMedGoogle Scholar
• Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015;41(3):374–388.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Tu LQ. Dermatophytes: diagnosis and treatment. J Am Acad Dermatol. 2006;54(6):1050–1055.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Foley KA, Versteeg SG. New antifungal agents and new formulations against dermatophytes. Mycopathologia. 2016. doi:10.1007/s11046-016-0045-0. [Epub ahead of print] ​​
   Google Scholar
• White TC, Findley K, Dawson TL Jr., et al. Fungi on the skin: dermatophytes and Malassezia. Cold Spring Harb Perspect Med. 2014;4:8.
   Web of Science ®Google Scholar
• Ilkit M. Favus of the scalp: an overview and update. Mycopathologia. 2010;170(3):143–154.
   PubMed Web of Science ®Google Scholar
• Achterman RR, Smith AR, Oliver BG, et al. Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model. Fungal Genetics and Biology: FG & B. 2011;48(3):335–341.
   PubMed Web of Science ®Google Scholar
• Gräser Y, El Fari M, Vilgalys R, et al. Phylogeny and taxonomy of the family Arthrodermataceae (dermatophytes) using sequence analysis of the ribosomal ITS region. Med Mycology. 1999;37(2):105–114.
   PubMed Web of Science ®Google Scholar
• Sugiyama M, Summerbell R, Mikawa T. Molecular phylogeny of onygenalean fungi based on small subunit (SSU) and large subunit (LSU) ribosomal DNA sequences. Stud Mycol. 2002;47:5–23.
   Google Scholar
• Nenoff P, Kruger C, Schaller J, et al. Mycology - an update part 2: dermatomycoses: clinical picture and diagnostics. J Dtsch Dermatol Ges. 2014;12(9):749–777.
   PubMed Web of Science ®Google Scholar
• Shemer A, Gupta AK, Farhi R, et al. When is onychomycosis? A cross-sectional study of fungi in normal-appearing nails. Br J Dermatol. 2015;172(2):380–383.
   PubMed Web of Science ®Google Scholar
• Ilkit M, Demirhindi H. Asymptomatic dermatophyte scalp carriage: laboratory diagnosis, epidemiology and management. Mycopathologia. 2008;165(2):61–71.
   PubMed Web of Science ®Google Scholar
• Seitz AT, Paasch U, Simon JC, et al. Tinea incognito. J Dtsch Dermatol Ges. 2013;11(11):1090–1093.
   PubMed Web of Science ®Google Scholar
• Gilaberte Y, Rezusta A, Gil J, et al. Tinea capitis in infants in their first year of life. Br J Dermatol. 2004;151(4):886–890.
   PubMed Web of Science ®Google Scholar
• Morell L, Fuente MJ, Boada A, et al. [Tinea capitis in elderly women: a report of 4 cases]. Actas Dermosifiliogr. 2012;103(2):144–148.
   PubMedGoogle Scholar
• Hiruma J, Ogawa Y, Hiruma M. Trichophyton tonsurans infection in Japan: epidemiology, clinical features, diagnosis and infection control. J Dermatol. 2015;42(3):245–249.
   PubMed Web of Science ®Google Scholar
• Ilkit M, Ali Saracli M, Kurdak H, et al. Clonal outbreak of Trichophyton tonsurans tinea capitis gladiatorum among wrestlers in Adana, Turkey. Med Mycology. 2010;48(3):480–485.
   PubMed Web of Science ®Google Scholar
• Deng S, Bulmer GS, Summerbell RC, et al. Changes in frequency of agents of tinea capitis in school children from Western China suggest slow migration rates in dermatophytes. Med Mycology. 2008;46(5):421–427.
   PubMed Web of Science ®Google Scholar
• Gräser Y, De Hoog S, Summerbell R. Dermatophytes: recognizing species of clonal fungi. Med Mycology. 2006;44(3):199–209.
   PubMed Web of Science ®Google Scholar
• Gomez-Moyano E, Crespo-Erchiga V. Tinea of vellus hair: an indication for systemic antifungal therapy. Br J Dermatol. 2010;163(3):603–606.
   PubMed Web of Science ®Google Scholar
• Veraldi S, Pontini P, Nazzaro G. A case of tinea ımbricata in an Italian woman. Acta Derm Venereol. 2015;95(2):235–237.
   PubMed Web of Science ®Google Scholar
• Bonifaz A, Vazquez-Gonzalez D. Tinea imbricata in the Americas. Curr Opin Infect Dis. 2011;24(2):106–111.
   PubMed Web of Science ®Google Scholar
• Veraldi S, Giorgi R, Pontini P, et al. Tinea ımbricata in an Italian child and review of the literature. Mycopathologia. 2015;180(5–6):353–357.
   PubMed Web of Science ®Google Scholar
• Hoque SR, Holden CA. Trichophyton tonsurans infection mimicking tinea imbricata. Clin Exp Dermatol. 2007;32(3):345–346.
   PubMed Web of Science ®Google Scholar
• Sonthalia S, Singal A, Das S. Tinea cruris and tinea corporis masquerading as tinea indecisiva: case report and review of the literature. J Cutan Med Surg. 2015;19(2):171–176.
   PubMed Web of Science ®Google Scholar
• Hay RJ, Ashbee HR. Mycology. In: Burns T, Breathnach S, Cox N, et al., Editors. Rook’s textbook of dermatology. Vol. 36. Oxford: Wiley-Blackwell; 2010. p. 18–36.65.
   Google Scholar
• Welsh O, Vera-Cabrera L. Red face and fungi infection. Clin Dermatol. 2014;32(6):734–738.
   PubMed Web of Science ®Google Scholar
• Zhan P, Ge YP, Lu XL, et al. A case-control analysis and laboratory study of the two feet-one hand syndrome in two dermatology hospitals in China. Clin Exp Dermatol. 2010;35(5):468–472.
   PubMed Web of Science ®Google Scholar
• Aste N, Pau M, Aste N. Tinea manuum bullosa. Mycoses. 2005;48(1):80–81.
   PubMed Web of Science ®Google Scholar
• Smith HR, Holloway D, Armstrong DK, et al. Association between tinea manuum and male manual workers. Contact Dermatitis. 2000;42(1):45.
   PubMed Web of Science ®Google Scholar
• Sweeney SM, Wiss K, Mallory SB. Inflammatory tinea pedis/manuum masquerading as bacterial cellulitis. Arch Pediatr Adolesc Med. 2002;156(11):1149–1152.
   PubMedGoogle Scholar
• Fernandes NC, Akiti T, Barreiros MG. Dermatophytoses in children: study of 137 cases. Rev Inst Med Trop Sao Paulo. 2001;43(2):83–85.
   PubMedGoogle Scholar
• Daniel CR 3rd, Jellinek NJ. The pedal fungus reservoir. Arch Dermatol. 2006;142(10):1344–1346.
   PubMedGoogle Scholar
• Daniel CR 3rd, Lawson LA. Tinea unguium. Cutis. 1987;40(4):326–327.
   PubMed Web of Science ®Google Scholar
• Caputo R, De Boulle K, Del Rosso J, et al. Prevalence of superficial fungal infections among sports-active individuals: results from the achilles survey, a review of the literature. J Eur Acad Dermatol Venereol. 2001;15(4):312–316.
   PubMed Web of Science ®Google Scholar
• Hirschmann JV, Raugi GJ. Pustular tinea pedis. J Am Acad Dermatol. 2000;42(1 Pt 1):132–133.
   PubMed Web of Science ®Google Scholar
• Qiangqiang Z, Limo Q, Qixian Q. Case report. Disseminated tinea of the verrucous type due to Epidermophyton floccosum. Mycoses. 2001;44(7–8):326–329.
   PubMed Web of Science ®Google Scholar
• Kamihama T, Kimura T, Hosokawa JI, et al. Tinea pedis outbreak in swimming pools in Japan. Public Health. 1997;111(4):249–253.
   PubMed Web of Science ®Google Scholar
• Attye A, Auger P, Joly J. Incidence of occult athlete’s foot in swimmers. Eur J Epidemiol. 1990;6(3):244–247.
   PubMed Web of Science ®Google Scholar
• Seyedmousavi S, Fataei E, Hashemi SJ, et al. Fungal flora in mineral swimming pools of Sarein-Iran. J Ardabil Univ Med Sci. 2005;7(2):146–154.
   Google Scholar
• Auger P, Marquis G, Joly J, et al. Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete’s foot. Mycoses. 1993;36(1–2):35–41.
   PubMed Web of Science ®Google Scholar
• Cribier BJ, Paul C. Long-term efficacy of antifungals in toenail onychomycosis: a critical review. Br J Dermatol. 2001;145(3):446–452.
   PubMed Web of Science ®Google Scholar
• Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician. 2013;88(11):762–770.
   PubMed Web of Science ®Google Scholar
• Finch J, Arenas R, Baran R. Fungal melanonychia. J Am Acad Dermatol. 2012;66(5):830–841.
   PubMed Web of Science ®Google Scholar
• Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol. 2011;65(6):1219–1227.
   PubMed Web of Science ®Google Scholar
• Daniel CR 3rd, Norton LA, Scher RK. The spectrum of nail disease in patients with human immunodeficiency virus infection. J Am Acad Dermatol. 1992;27(1):93–97.
   PubMed Web of Science ®Google Scholar
• Tosti A, Baran R, Piraccini BM, et al. “Endonyx” onychomycosis: a new modality of nail invasion by dermatophytes. Acta Derm Venereol. 1999;79(1):52–53.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Summerbell RC. Combined distal and lateral subungual and white superficial onychomycosis in the toenails. J Am Acad Dermatol. 1999;41(6):938–944.
   PubMed Web of Science ®Google Scholar
• Blank H, Smith JG Jr. Widespread Trichophyton rubrum granulomas treated with griseofulvin. Arch Dermatol. 1960;81:779–789.
   PubMedGoogle Scholar
• Janniger CK. Majocchi’s granuloma. Cutis. 1992;50(4):267–268.
   PubMed Web of Science ®Google Scholar
• Wilson JW, Plunkett OA, Gregersen A. Nodular granulomatous perifolliculitis of the legs caused by Trichophyton rubrum. AMA Arch Derm Syphilol. 1954;69(3):258–277.
   PubMedGoogle Scholar
• Chang SE, Lee DK, Choi JH, et al. Majocchi’s granuloma of the vulva caused by Trichophyton mentagrophytes. Mycoses. 2005;48(6):382–384.
   PubMed Web of Science ®Google Scholar
• Novick NL, Tapia L, Bottone EJ. Invasive Trichophyton rubrum infection in an immunocompromised host. Case report and review of the literature. Am J Med. 1987;82(2):321–325.
   PubMed Web of Science ®Google Scholar
• Radentz WH, Yanase DJ. Papular lesions in an immunocompromised patient. Trichophyton rubrum granulomas (Majocchi’s granuloma). Arch Dermatol. 1993;129(9):1189-1190, 1192-1183.
   PubMedGoogle Scholar
• Isa-Isa R, Arenas R, Isa M. Inflammatory tinea capitis: kerion, dermatophytic granuloma, and mycetoma. Clin Dermatol. 2010;28(2):133–136.
   PubMed Web of Science ®Google Scholar
• Grappel SF, Bishop CT, Blank F. Immunology of dermatophytes and dermatophytosis. Bacteriol Rev. 1974;38(2):222–250.
   PubMedGoogle Scholar
• Al Hasan M, Fitzgerald SM, Saoudian M, et al. Dermatology for the practicing allergist: tinea pedis and its complications. Clin Mol Allergy. 2004;2(1):5.
   PubMedGoogle Scholar
• Kaaman T, Torssander J. Dermatophytid–a misdiagnosed entity? Acta Derm Venereol. 1983;63(5):404–408.
   PubMed Web of Science ®Google Scholar
• Dostrovsky A, Kallner G, Raubitschek F, et al. Tinea capitis: an epidemiologic, therapeutic and laboratory investigation of 6,390 cases. J Invest Dermatol. 1955;24(3):195–200.
   PubMed Web of Science ®Google Scholar
• Veien NK, Hattel T, Laurberg G. Plantar Trichophyton rubrum infections may cause dermatophytids on the hands. Acta Derm Venereol. 1994;74(5):403–404.
   PubMed Web of Science ®Google Scholar
• Romano C, Rubegni P, Ghilardi A, et al. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum. Mycoses. 2006;49(3):249–250.
   PubMed Web of Science ®Google Scholar
• Atzori L, Pau M, Aste M. Erythema multiforme ID reaction in atypical dermatophytosis: a case report. J Eur Acad Dermatol Venereol. 2003;17(6):699–701.
   PubMed Web of Science ®Google Scholar
• Verrier J, Monod M. Diagnosis of Dermatophytosis Using Molecular Biology. Mycopathologia. 2016. doi:10.1007/s11046-016-0038-z. [Epub ahead of print] ​​
   PubMedGoogle Scholar
• Bergmans AM, Van Der Ent M, Klaassen A, et al. Evaluation of a single-tube real-time PCR for detection and identification of 11 dermatophyte species in clinical material. Clin Microbiol Infect. 2010;16(6):704–710.
   PubMed Web of Science ®Google Scholar
• Robert R, Pihet M. Conventional methods for the diagnosis of dermatophytosis. Mycopathologia. 2008;166(5–6):295–306.
   PubMed Web of Science ®Google Scholar
• Nenoff P, Kruger C, Paasch U, et al. Mycology - an update part 3: dermatomycoses: topical and systemic therapy. J Dtsch Dermatol Ges. 2015;13(5):387-410; quiz 411.
   PubMed Web of Science ®Google Scholar
• Gray KC, Palacios DS, Dailey I, et al. Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci U S A. 2012;109(7):2234–2239.
   PubMed Web of Science ®Google Scholar
• De Kruijff B, Gerritsen WJ, Oerlemans A, et al. Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. I. specificity of the membrane permeability changes induced by the polyene antibiotics. Biochim Biophys Acta. 1974;339(1):30–43.
   PubMed Web of Science ®Google Scholar
• Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta. 1986;864(3–4):257–304.
   PubMed Web of Science ®Google Scholar
• Maertens JA. History of the development of azole derivatives. Clin Microbiol Infect. 2004;10(Suppl 1):1–10.
   PubMed Web of Science ®Google Scholar
• Groll AH, Gea-Banacloche JC, Glasmacher A, et al. Clinical pharmacology of antifungal compounds. Infect Dis Clin North Am. 2003;17(1):159–191, ix.
   PubMed Web of Science ®Google Scholar
• Mohr J, Johnson M, Cooper T, et al. Current options in antifungal pharmacotherapy. Pharmacotherapy. 2008;28(5):614–645.
   PubMed Web of Science ®Google Scholar
• Lass-Florl C. Triazole antifungal agents in invasive fungal infections: a comparative review. Drugs. 2011;71(18):2405–2419.
   PubMed Web of Science ®Google Scholar
• EMA. European public assessment report (EPAR) for Noxafil. European Medicines Agency; 2012. London, United Kingdom (www.ema.europa.eu). ​​
   Google Scholar
• EMA. European public assessment report (EPAR) for Vfend. European Medicines Agency; 2012. London, United Kingdom (www.ema.europa.eu). ​​
   Google Scholar
• Warrilow AG, Martel CM, Parker JE, et al. Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51). Antimicrob Agents Chemother. 2010;54(10):4235–4245.
   PubMed Web of Science ®Google Scholar
• Denning DW. Echinocandins: a new class of antifungal. J Antimicrob Chemother. 2002;49(6):889–891.
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Sheehan D, Puzniak L, et al. Echinocandins: are they all the same? J Chemotherapy. 2011;23(6):319–325.
   PubMed Web of Science ®Google Scholar
• Nyfeler R, Keller-Schierlein W. Metabolites of microorganisms. 143. Echinocandin B, a novel polypeptide-antibiotic from Aspergillus nidulans var. echinulatus: isolation and structural components. Helv Chim Acta. 1974;57(8):2459–2477.
   PubMed Web of Science ®Google Scholar
• Kurtz MB, Douglas CM. Lipopeptide inhibitors of fungal glucan synthase. J Med Vet Mycol. 1997;35(2):79–86.
   PubMedGoogle Scholar
• Eschenauer G, Depestel DD, Carver PL. Comparison of echinocandin antifungals. Ther Clin Risk Manag. 2007;3(1):71–97.
   PubMedGoogle Scholar
• Tassel D, Madoff MA. Treatment of Candida sepsis and cryptococcus meningitis with 5-fluorocytosine. A new antifungal agent. Jama. 1968;206(4):830–832.
   PubMed Web of Science ®Google Scholar
• Heidelberger C, Chaudhuri NK, Danneberg P, et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature. 1957;179(4561):663–666.
   PubMed Web of Science ®Google Scholar
• Polak A, Scholer HJ. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy. 1975;21(3–4):113–130.
   PubMed Web of Science ®Google Scholar
• Cutler RE, Blair AD, Kelly MR. Flucytosine kinetics in subjects with normal and impaired renal function. Clin Pharmacol Ther. 1978;24(3):333–342.
   PubMed Web of Science ®Google Scholar
• Zomorodian K, Uthman U, Tarazooie B, et al. The effect of griseofulvin on the gene regulation of beta-tubulin in the dermatophyte pathogen Trichophyton rubrum. J Infect Chemother. 2007;13(6):373–379.
   PubMedGoogle Scholar
• Lewis RE. Current concepts in antifungal pharmacology. Mayo Clinic Proceedings. 2011;86(8):805–817.
   PubMed Web of Science ®Google Scholar
• Shemer A, Plotnik IB, Davidovici B, et al. Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study. J Dtsch Dermatol Ges. 2013;11(8):737-741, 737-742.
   PubMed Web of Science ®Google Scholar
• Elewski BE. Treatment of tinea capitis: beyond griseofulvin. J Am Acad Dermatol. 1999;40(6 Pt 2):S27–30.
   PubMed Web of Science ®Google Scholar
• Chen BK, Friedlander SF. Tinea capitis update: a continuing conflict with an old adversary. Curr Opin Pediatr. 2001;13(4):331–335.
   PubMed Web of Science ®Google Scholar
• Shear NH, Villars VV, Marsolais C. Terbinafine: an oral and topical antifungal agent. Clin Dermatol. 1991;9(4):487–495.
   PubMed Web of Science ®Google Scholar
• Krishnan-Natesan S. Terbinafine: a pharmacological and clinical review. Expert Opin Pharmacother. 2009;10(16):2723–2733.
   PubMed Web of Science ®Google Scholar
• Favre B, Ryder NS. Characterization of squalene epoxidase activity from the dermatophyte trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Antimicrob Agents Chemother. 1996;40(2):443–447.
   PubMed Web of Science ®Google Scholar
• Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126(Suppl 39):2–7.
   PubMed Web of Science ®Google Scholar
• Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol. 1994;19(2):121–126.
   PubMed Web of Science ®Google Scholar
• Grover C, Arora P, Manchanda V. Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis. Int J Dermatol. 2012;51(4):455–458.
   PubMed Web of Science ®Google Scholar
• Deng S, Hu H, Abliz P, et al. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China. Mycopathologia. 2011;172(5):365–372.
   PubMed Web of Science ®Google Scholar
• Jaiswal A, Sharma RP, Garg AP. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. Indian J Dermatol Venereol Leprol. 2007;73(6):393–396.
   PubMed Web of Science ®Google Scholar
• Hall M, Monka C, Krupp P, et al. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients. Arch Dermatol. 1997;133(10):1213–1219.
   PubMed Web of Science ®Google Scholar
• EMA. European public assessment report (EPAR) for Diflucan. European Medicines Agency; 2012. London, United Kingdom (www.ema.europa.eu). ​​
   Google Scholar
• Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis. 1990;12(Suppl 3):S318–326.
   PubMedGoogle Scholar
• Schauder S. Itraconazole in the treatment of tinea capitis in children. Case reports with long-term follow-up evaluation. Review of the literature. Mycoses. 2002;45(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Fernandez-Torres B, Carrillo AJ, Martin E, et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother. 2001;45(9):2524–2528.
   PubMed Web of Science ®Google Scholar
• Yenisehirli G, Tuncoglu E, Yenisehirli A, et al. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey. Int J Dermatol. 2013;52(12):1557–1560.
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Wraith LA, Cai B, et al. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial. Br J Dermatol. 2008;159(3):711–713.
   PubMed Web of Science ®Google Scholar
• Singh J, Zaman M, Gupta AK. Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes. Med Mycol. 2007;45(7):595–602.
   PubMed Web of Science ®Google Scholar
• Ghannoum M, Isham N, Sheehan D. Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial. J Clin Microbiol. 2006;44(7):2579–2580.
   PubMed Web of Science ®Google Scholar
• Bao YQ, Wan Z, Li RY. In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China. Mycopathologia. 2013;175(1–2):141–145.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008;166(5–6):353–367.
   PubMed Web of Science ®Google Scholar
• Sugiura K, Sugimoto N, Hosaka S, et al. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment. Antimicrob Agents Chemother. 2014;58(7):3837–3842.
   PubMed Web of Science ®Google Scholar
• Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration. Skin Pharmacol Physiol. 2006;19(2):106–121.
   PubMed Web of Science ®Google Scholar
• Van Zuuren EJ, Fedorowicz Z, El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Br J Dermatol. 2015;172(3):616–641.
   PubMed Web of Science ®Google Scholar
• Gupta AK. Butenafine: an update of its use in superficial mycoses. Skin Therapy Lett. 2002;7(7):1–2, 5.
   Google Scholar
• Khanna D, Bharti S. Luliconazole for the treatment of fungal infections: an evidence-based review. Core Evid. 2014;9:113–124.
   PubMedGoogle Scholar